CS and B-cell non-Hodgkin lymphoma: Seventy-five percent (34 of 46) of all canonical pathways altered by the genes that are significantly mutated in Cs B-cell lymphomas are also implicated for the Gr B-cell lymphoma tumors (Table 3; Supplemental Table S4).